Sanofi India Q2 profit rises 33% to Rs85 crore
- US FCC to vote to repeal net neutrality rules: chief Ajit Pai
- Satin Creditcare subsidiary gets housing finance licence
- Robert Mugabe ends 37-year Zimbabwe rule under impeachment threat
- Brics Bank approves $400 million loans for India, Russia
- Oxford University sued over grades by student who couldn’t get into Harvard
New Delhi: Drug firm Sanofi India Ltd on Friday reported a 32.86% rise in standalone net profit to Rs.85.3 crore for the second quarter ended 30 June 2016.
The company had reported had posted a net profit of Rs.64.2 crore for the corresponding period of the previous fiscal, Sanofi India said in a filing to BSE.
Standalone total income from operations of the company also rose to Rs.608 crore for the quarter under consideration as against Rs.549.7 crore for the same period year ago.
In a separate filing, the company, which follows January-December as its fiscal, said it’s board of directors has declared an interim dividend of Rs.18 per equity share of Rs.10 each.
Shares of the company on Friday closed 0.32% down at Rs.4,500.05 a scrip on BSE.